Total Payments
$5,157
2022 Payments
$13.89
Companies
34
Transactions
524
Medicare Patients
3,856
Medicare Billing
$301,298
Payment Breakdown by Category
Food & Beverage$5,030 (97.5%)
Consulting$100.00 (1.9%)
Education$26.92 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,030 | 518 | 97.5% |
| Consulting Fee | $100.00 | 1 | 1.9% |
| Education | $26.92 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $903.06 | 102 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $759.60 | 22 | $0 (2019) |
| Novo Nordisk Inc | $677.66 | 75 | $0 (2019) |
| Amgen Inc. | $378.46 | 40 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $355.99 | 53 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $309.73 | 44 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $205.03 | 43 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $200.59 | 17 | $0 (2019) |
| Purdue Pharma L.P. | $178.10 | 20 | $0 (2018) |
| AbbVie, Inc. | $160.18 | 22 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.89 | 1 | Amgen Inc. ($13.89) |
| 2019 | $966.07 | 89 | PFIZER INC. ($195.03) |
| 2018 | $1,965 | 169 | PFIZER INC. ($417.69) |
| 2017 | $2,212 | 265 | PFIZER INC. ($290.34) |
All Payment Transactions
524 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2022 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 10/27/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $41.06 | General |
| 07/23/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: Neuroscience | ||||||
| 07/22/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Respiratory | ||||||
| 07/18/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: Neuroscience | ||||||
| 07/17/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Endocrinology | ||||||
| 07/15/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/11/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Neuroscience | ||||||
| 07/10/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Central Nervous System (CNS) | ||||||
| 07/09/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/03/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/28/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $5.02 | General |
| Category: Diabetes | ||||||
| 06/25/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/21/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: Diabetes | ||||||
| 06/20/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $2.85 | General |
| Category: Diabetes | ||||||
| 06/19/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: DIABETES | ||||||
| 06/17/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: Bone Health | ||||||
| 06/14/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Neuroscience | ||||||
| 06/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: Diabetes | ||||||
| 06/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/05/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: Diabetes | ||||||
| 06/04/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 06/03/2019 | Merck Sharp & Dohme Corporation | ROTATEQ (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: VACCINE | ||||||
| 05/31/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Diabetes | ||||||
| 05/29/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 752 | 2,197 | $229,813 | $96,578 |
| 2022 | 13 | 876 | 1,534 | $152,300 | $63,635 |
| 2021 | 14 | 1,008 | 1,715 | $139,289 | $70,124 |
| 2020 | 21 | 1,220 | 2,176 | $161,527 | $70,962 |
Total Patients
3,856
Total Services
7,622
Medicare Billing
$301,298
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 258 | 487 | $103,984 | $36,183 | 34.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 1,020 | $38,760 | $18,705 | 48.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 323 | $45,955 | $17,304 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 70 | 70 | $9,800 | $8,514 | 86.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $5,392 | $4,512 | 83.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 26 | 26 | $10,634 | $3,864 | 36.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 44 | 45 | $4,995 | $3,227 | 64.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $3,804 | $1,571 | 41.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 48 | $2,064 | $1,373 | 66.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $1,247 | $829.40 | 66.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 48 | $2,496 | $412.62 | 16.5% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 19 | 21 | $630.00 | $81.54 | 12.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 52 | $52.00 | $3.87 | 7.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 244 | 474 | $84,066 | $34,273 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 159 | 334 | $42,392 | $17,831 | 42.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 42 | 42 | $4,662 | $2,879 | 61.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 16 | $5,554 | $2,444 | 44.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 58 | 58 | $2,494 | $1,590 | 63.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $2,148 | $1,448 | 67.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 212 | 384 | $5,539 | $1,126 | 20.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 28 | 28 | $1,078 | $771.68 | 71.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 26 | 35 | $1,400 | $513.88 | 36.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 40 | $1,860 | $337.78 | 18.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 17 | 17 | $629.00 | $337.44 | 53.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 31 | 35 | $418.00 | $77.82 | 18.6% |
About Dr. Dan Mccarty, DO
Dr. Dan Mccarty, DO is a Family Medicine healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780641613.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dan Mccarty, DO has received a total of $5,157 in payments from pharmaceutical and medical device companies, with $13.89 received in 2022. These payments were reported across 524 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,030).
As a Medicare-enrolled provider, Mccarty has provided services to 3,856 Medicare beneficiaries, totaling 7,622 services with total Medicare billing of $301,298. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wichita, KS
- Active Since 04/26/2006
- Last Updated 09/26/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780641613
Products in Payments
- CHANTIX (Drug) $438.88
- FARXIGA (Drug) $414.70
- Victoza (Drug) $316.16
- Trintellix (Drug) $302.85
- Prolia (Biological) $222.03
- SYMBICORT (Drug) $187.75
- VIAGRA (Drug) $184.62
- Saxenda (Drug) $172.77
- LYRICA (Drug) $163.26
- JANUVIA (Drug) $162.15
- ROTATEQ (Biological) $141.05
- JARDIANCE (Drug) $136.62
- XARELTO (Drug) $126.94
- Ozempic (Drug) $124.95
- STIOLTO (Drug) $114.85
- EUCRISA (Drug) $114.10
- EMGALITY (Drug) $88.15
- MYRBETRIQ (Drug) $79.63
- INVOKANA (Drug) $78.09
- VYVANSE (Drug) $76.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wichita
Dr. Mila Means, M.d, M.D
Family Medicine — Payments: $248,802
Family Medicine $248,802
Cole Gillenwater, M.d, M.D
Family Medicine — Payments: $53,886
Family Medicine $53,886
Dr. Richard Egelhof, M.d, M.D
Family Medicine — Payments: $38,988
Family Medicine $38,988
Dr. Hai Truong, D.o, D.O
Family Medicine — Payments: $31,271
Family Medicine $31,271
Deborah Outwater, M.d, M.D
Family Medicine — Payments: $28,643
Family Medicine $28,643
Dr. Tara Neil, Md, MD
Family Medicine — Payments: $24,299
Family Medicine $24,299